RadNet Inc. (RDNT)
65.56
-1.03 (-1.55%)
At close: Jan 14, 2025, 3:59 PM
65.20
-0.55%
Pre-market Jan 15, 2025, 06:21 AM EST
undefined% (undefined)
| Bid | 48.87 |
| Market Cap | 4.85B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.07 |
| PE Ratio (ttm) | -936.57 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 105.04 |
| Volume | 678,029 |
| Avg. Volume (20D) | 520,116 |
| Open | 67.15 |
| Previous Close | 66.59 |
| Day's Range | 65.08 - 68.18 |
| 52-Week Range | 35.16 - 93.65 |
| Beta | undefined |
About RDNT
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imagin...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jan 3, 1997
Employees 10,000
Stock Exchange NASDAQ
Ticker Symbol RDNT
Website https://www.radnet.com
Analyst Forecast
According to 4 analyst ratings, the average rating for RDNT stock is "Strong Buy." The 12-month stock price forecast is $89.5, which is an increase of 36.52% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
RadNet Inc. is scheduled to release its earnings on Feb 27, 2025,
during market hours.
Analysts project revenue of $467.37M, reflecting a 11.18% YoY growth and earnings per share of 0.24, making a 20.00% increase YoY.
Analysts project revenue of $467.37M, reflecting a 11.18% YoY growth and earnings per share of 0.24, making a 20.00% increase YoY.
2 months ago ·
Source
+19.1%
RadNet shares are trading higher after the company...
Unlock content with
Pro Subscription
5 months ago ·
Source
+8.4%
RadNet shares are trading higher after the company reported better-than-expected Q2 revenue results. Also, Barclays raised its price target on the stock from $51 to $57.
